Paul Edward Gross, See Remarks at Clovis Oncology, Inc. (CLVS), sold 21,128 shares at $7.97 ($168K) on 2021-02-02, disclosed to the SEC on 2021-02-03.
Open-market sale of $168k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.97 | 1,187 | $9K | 5.6% |
| 2 | $7.97 | 1,431 | $11K | 6.8% |
| 3 | $7.97 | 9,255 | $74K | 43.8% |
| 4 | $7.97 | 9,255 | $74K | 43.8% |
| Total | $7.97 avg | 21,128 | $168K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $2K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |